Women's Health Policy

ABORTION IN THE U.S.

Variability in Rebimbursement Rates for State-funded Abortion Services for Medicaid Enrollees: A 2026 Update

This analysis reveals that while more states have begun using their own funds to cover abortion services for Medicaid enrollees since the U.S. Supreme Court’s Dobbs decision, only a handful have significantly increased reimbursement rates for providers, potentially undermining access to care for low-income patients. After examining physician fee schedules for abortions provided to Medicaid enrollees since 2024, KFF finds that reimbursement rates vary dramatically across states, and that most states don't substantially increase payment rates for later-pregnancy procedures, despite their higher costs and complexity.

CONTRACEPTIve care IN THE U.S.

SELECTED RESOURCES

Over-the-Counter Oral Contraceptive Pills

In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.

featured

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Women’s Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials
  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.
  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.
  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.
  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Stay informed.

Stay informed.

Filter

391-400 of 875 results

  • Abortion Back at the Supreme Court: June Medical Services LLC v. Russo

    Issue Brief

    This issue brief explains the legal and factual issues in dispute and the reviews the potential implications of different rulings in the case of June Medical Services v. Russo, which could have significant implications for women’s access to abortion and could eliminate the right of abortion providers to bring legal challenges to state and federal laws and policies.

  • Potential Impacts of Delaying “Non-Essential” Reproductive Health Care

    Issue Brief

    This brief analyzes how states, health systems and providers have been faced with deciding what health care is “essential” verses “elective” during the COVID-19 crisis, and what the possible consequences are to delays in "non-essential" reproductive health care.

  • At-Home SARS-CoV-2 Testing: What Are the Options?

    Interactive

    This interactive table includes vendors selling at-home SARS-CoV-2 diagnostic tests that have received emergency use authorization (EUA) from the Food and Drug Administration (FDA).

  • COVID-19 Puts Medication Abortion in the Spotlight

    News Release

    A new Coronavirus Policy Watch post from KFF explores how state responses to limit abortion access during the COVID-19 pandemic has drawn renewed attention to the provision of medication abortion using telemedicine approaches.  Medication abortion via telemedicine is a method that can be used to safely provide women with access to abortion care while social distancing, preserving personal protective equipment, and limiting risk of exposure to coronavirus. A new telemedicine protocol --“no-test” medication abortions-- has…

  • New Analysis Reveals Gaps in Abortion Coverage for Employees with Employer-Sponsored Plans

    News Release

    New analysis of KFF’s 2019 Employer Benefits Survey finds that 10% of workers covered by employer-sponsored health insurance are employed at a firm that has asked their insurer or third party administrator to exclude abortion coverage from their health plan. Employer-sponsored coverage is the primary source of health benefits in the U.S., covering 153 million Americans. Four percent of covered workers are employed at firms that exclude coverage of abortion under any circumstance and 6%…